Non Invasive Fat Reduction Market

Market Synopsis:

Global Non Invasive Fat Reduction market is valued at USD 579.2 Million in 2021 and is projected to attain a value of USD 1903.2 Million by 2028 at a CAGR of 16.9% during the forecast period, 2022–2028. Non-invasive fat reduction is a non-surgical fat reduction aesthetic process that uses cryolipolysis, radiofrequency, and laser lipolysis to reduce or eradicate persistent fat pockets in specific parts of the body. The FDA has approved the devices used in these treatments to permanently eliminate fat cells because they have been studied for efficiency and safety, and the findings have been confirmed to show significant results. These therapies must be performed by qualified professionals who are technically proficient. CoolSculpting, Kybella, Vanquish, and Sculpsure are some of the most well-known non-invasive fat reduction brands.

The COVID-19 pandemic has wreaked havoc on the global population and economy. Across the globe, the COVID-19 pandemic caused substantial obstacles to the health-care system. Due to the imposition of lockdown, which resulted in trade restrictions and supply chain disruptions, it had a negative impact on the growth of the surgical apparel market for a short period of time. In addition, many non-essential medical and surgical treatments were halted, which had an impact on market growth.

Rise in Healthcare Expenditure

According to the World Health Organization, a sedentary lifestyle is a primary contributor to obesity, sickness, and disability. Obesity is responsible for over 2.0 million deaths per year. Physical inactivity, sedentary and long work hours, and behavioral risk factors such as alcohol drinking, smoking, and stress are all contributing to an unhealthy lifestyle, which has resulted in diseases such as diabetes and obesity. People currently have less time to focus on their physical health as a result of urbanization, and they seek for alternative methods to combat or eliminate stubborn fat. Increased acceptance and demand for body contouring procedures, as well as an increase in health-care spending and an increase in the prevalence of obesity, are driving the expansion of the non-invasive fat reduction industry.

High Cost Involved in the Research and Development

The high cost of obesity drug research and development, along with limited financial assistance, pose a significant impediment to the obesity management market's growth. Furthermore, longer research and development efforts, as well as the inclusion of clinical trials to evaluate pharmaceuticals, raise overall costs. As a result, given the current situation, producers must exercise caution and ensure that they invest in markets that deliver a higher return on investment.

The risks and constraints posed by obesity medications' high development costs could stifle worldwide market expansion. Due to the high cost of surgical procedures such as gastric bypass, adjustable gastric banding, gastric sleeve surgery, and intragastric balloon treatment, non-invasive fat reduction technologies are becoming more popular.

The Non Invasive Fat Reduction market scope can be tabulated as below:

Market Segmentation:

The Global Non Invasive Fat Reduction Market has been segmented by Technology into Cryolipolysis, Ultrasound, Low Level Lasers and Others. Based on End-Use into Hospitals, Stand, Alone Practices, Multi-specialty Clinics and Others. Based on Region, the Non Invasive Fat Reduction Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

North America to Continue Dominating the Non Invasive Fat Reduction Market

North America, Europe, and Asia Pacific accounted for the greatest proportion of the Non Invasive Fat Reduction market in 2021. Factors such as the increase in the number of well-established Non Invasive Fat Reduction companies and research institutes in the United States and Canada, a large number of ongoing research studies, and the overall growth of the healthcare sector on a global scale are among the few factors expected to contribute to the market's growth. The regional market growth can be attributed to expanding geriatric populace, increasing surgical procedures, expanding and presence of established healthcare infrastructure. One of the primary causes leading to the growing demand for Non Invasive Fat Reduction techniques and technologies among academic and research organisations, as well as healthcare firms in North America, is increased R&D spending.

Key Players:

Key participants operating in the Non Invasive Fat Reduction market are: Cutera Inc (US), Hologic Inc (US), Candela Corporation (US), Bausch Health Companies (Canada), Alma Lasers (Israel) are the major companies operating in Non-Invasive Fat Reduction Market.

The Non Invasive Fat Reduction market is segmented as follows: